Patents/Inventors

Claire Mégret

LyonsFR22 patents

27 Patents

US125514572026
Modified Release Gamma-hydroxybutyrate Formulations Having Improved Pharmacokinetics
Flamel Ireland Limited
0 cites
US122959262025
Modified Release Gamma-hydroxybutyrate Formulations Having Improved Pharmacokinetics
Flamel Ireland Limited
0 cites
US122631502025
Modified Release Gamma-hydroxybutyrate Formulations Having Improved Pharmacokinetics
Flamel Ireland Limited
0 cites
US122631512025
Modified Release Gamma-hydroxybutyrate Formulations Having Improved Pharmacokinetics
Flamel Ireland Limited
0 cites
US122572232025
Modified Release Gamma-hydroxybutyrate Formulations Having Improved Pharmacokinetics
Flamel Ireland Limited
0 cites
US122396252025
Modified Release Gamma-hydroxybutyrate Formulations Having Improved Pharmacokinetics
Flamel Ireland Limited
0 cites
US122263882025
Modified Release Gamma- Hydroxybutyrate Formulations Having Improved Pharmacokinetics
Flamel Ireland Limited
0 cites
US122263892025
Modified Release Gamma-hydroxybutyrate Formulations Having Improved Pharmacokinetics
Flamel Ireland Limited
0 cites
US121862982025
Modified Release Gamma-hydroxybutyrate Formulations Having Improved Pharmacokinetics
Flamel Ireland Limited
0 cites
US121447932024
Modified Release Gamma-hydroxybutyrate Formulations Having Improved Pharmacokinetics
Flamel Ireland Limited
0 cites
US121382392024
Modified Release Gamma-hydroxybutyrate Formulations Having Improved Pharmacokinetics
FLAMEL IRELAND LIMITED
0 cites
US121280212024
Modified Release Gamma-hydroxybutyrate Formulations Having Improved Pharmacokinetics
Flamel Ireland Limited
0 cites
US121151422024
Modified Release Gamma-hydroxybutyrate Formulations Having Improved Pharmacokinetics
Flamel Ireland Limited
0 cites
US121151432024
Modified Release Gamma-hydroxybutyrate Formulations Having Improved Pharmacokinetics
Flamel Ireland Limited
0 cites
US121151442024
Modified Release Gamma-hydroxybutyrate Formulations Having Improved Pharmacokinetics
Flamel Ireland Limited
0 cites
US121151452024
Modified Release Gamma-hydroxybutyrate Formulations Having Improved Pharmacokinetics
Flamel Ireland Limited
0 cites
US121091862024
Modified Release Gamma-hydroxybutyrate Formulations Having Improved Pharmacokinetics
Flamel Ireland Limited
0 cites
US120971752024
Modified Release Gamma-hydroxybutyrate Formulations Having Improved Pharmacokinetics
Flamel Ireland Limited
0 cites
US120971762024
Modified Release Gamma-hydroxybutyrate Formulations Having Improved Pharmacokinetics
FLAMEL IRELAND LIMITED
0 cites
US119864512024
Modified Release Gamma-hydroxybutyrate Formulations Having Improved Pharmacokinetics
Flamel Ireland Limited
0 cites
US118965722024
Modified Release Gamma-hydroxybutyrate Formulations Having Improved Pharmacokinetics
Flamel Ireland Limited
0 cites
US118263352023
Modified Release Gamma-hydroxybutyrate Formulations Having Improved Pharmacokinetics
Flamel Ireland Limited
0 cites
US117795572023
Modified Release Gamma-hydroxybutyrate Formulations Having Improved Pharmacokinetics
Flamel Ireland Limited
0 cites
US117664182023
Modified Release Gamma-hydroxybutyrate Formulations Having Improved Pharmacokinetics
Flamel Ireland Limited
0 cites
US116025122023
Modified Release Gamma-hydroxybutyrate Formulations Having Improved Pharmacokinetics
Flamel Ireland Limited
0 cites
US116025132023
Modified Release Gamma-hydroxybutyrate Formulations Having Improved Pharmacokinetics
Flamel Ireland Limited
0 cites
US115835102023
Methods of Administering Gamma Hydroxybutyrate Formulations After a High-fat Meal
Flamel Ireland Limited
0 cites